Back to Market返回行情

WRBY Warby Parker Inc.

USHealthcare
$29.32+5.96%ClosedMarket Cap: $3.60B

As of 2026-07-09 16:00

Why WRBY matters now

Warby Parker Inc. (WRBY) is a US stock in Healthcare. The latest InvestLog snapshot shows $29.32 with +5.96% on the session and $3.60B in market capitalization; recent performance reads 1-month +1.76% and YTD +19.14%.

The latest financial table shown here is Q1 2026, with revenue of $242.4M, net income of $3.2M, and EPS of $0.03. Investors can compare that operating picture with valuation signals such as P/E 1581.15 and FCF yield 1.2%.

The latest indexable market news headline is "Warby Parker Has 'Plenty More Than Meets The Eye', Analyst Says" from Benzinga.

Additional event context on this page matters because analyst consensus is Buy with a median target of $31.50; recent insider activity includes Briggs Teresa filing S-Sale. These signals are research inputs, not a recommendation.

Valuation

P/E (TTM)

1581.15

PEG

14.63

P/B

8.53

P/S

3.58

EV/EBITDA

58.06

DCF Value

$-13.78

FCF Yield

1.2%

Div Yield

0.0%

Margins & Returns

Gross Margin

53.4%

Operating Margin

-0.7%

Net Margin

0.2%

ROE

0.4%

ROA

0.2%

ROIC

-0.6%

Financials

PeriodRevenueNet IncomeEPS
Q1 2026$242.4M$3.2M$0.03
Q4 2025$212.0M$-6.0M$-0.05
FY 2025$871.9M$1.6M$0.01
Q3 2025$221.7M$5.9M$0.05

Analyst Ratings

Consensus

Buy

Target (Consensus)

$31.00

Target (Median)

$31.50

Target Range

$27.00 - $34.00

Strong Buy: 2Buy: 7Hold: 4Sell: 0Strong Sell: 0
UBSNeutral
2026-05-08
BTIGBuy
2026-05-07
CitigroupNeutral
2026-03-17
Telsey Advisory GroupOutperform
2026-02-20
Piper SandlerOverweight
2025-12-16

Trading Activity

Insider Trades

Briggs Teresadirector
Sell2026-06-18
Briggs Teresadirector
Sell2026-06-18
Moon Youngme Edirector
Sell2026-06-12
Briggs Teresadirector
Sell2026-06-10
Moon Youngme Edirector
Sell2026-06-10

Company Info

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Country

US

Exchange

Beta

1.97

Warby Parker Inc. operates as a purveyor of optical products and related services. Their extensive product line includes prescription eyeglasses, sunglasses, and contact lenses, alongside specialized lens options such as light-responsive (photochromic) and blue-light-filtering variants. Customers can also acquire a variety of accessories, including protective cases, lens care kits equipped with anti-fog spray, pouches, and individual anti-fog lens sprays. Beyond product sales, Warby Parker facilitates direct-to-consumer eye examinations and vision assessments. These services are accessible through their physical retail locations, online platform, and dedicated mobile applications. By May 16, 2022, the company had established a network of 160 brick-and-mortar stores across the United States and Canada. Originally incorporated as JAND, Inc. in 2009, the organization officially rebranded to Warby Parker Inc. in June 2021. Its corporate headquarters are situated in New York, New York.